Crossmark

Intramuscularly injected long-acting testosterone-cholesterol prodrug suspension with three different particle sizes: extended in vitro release and enhanced in vivo safety

Crossref DOI link: https://doi.org/10.1007/s13346-023-01460-2

Published Online: 2023-11-06

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Shuo

Wang, Zhaomeng

Yu, Jiang

Zhang, Chuang

Ye, Jianying

Liu, Hengzhi

Jiang, Yiguo

He, Zhonggui

Wang, Yongjun
License Information

Text and Data Mining valid from 2023-11-06

Version of Record valid from 2023-11-06
More Information

Article History

Accepted: 21 October 2023

First Online: 6 November 2023

Declarations

:

: All animal experiments were approved by the Animal Ethics Committee of Shenyang Pharmaceutical University and carried out under the Guidelines for the Care and Use of Laboratory Animals.

: All authors approved the manuscript and the submission to this journal.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below